Integrating biobanks: addressing the practical and ethical issues to deliver a valuable tool for cancer research
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Cancer is caused by complex interactions between genes, environment and lifestyles. Biobanks of well-annotated human tissues are an important resource for studying the underlying mechanisms of cancer. Although such biobanks exist, their integration to form larger biobanks is now required to provide the diversity of samples that are needed to study the complexity and heterogeneity of cancer. Clear guidelines and policies are also required to address the challenges of integrating individual institutional or national biobanks and build public trust. This Science and Society article highlights some of the main practical and ethical issues that are undergoing discussion in the integration of tissue biobanks for cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Misinterpretation is a concern when data are assessed without assistance, e.g. from a trained clinician, carer or data scientist (Watson et al. 2010).”
From Ethics of the health-related internet of things: a narrative review (2017) · cites this paper as Watson et al. 2010
Citations
Cites
Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia.
Cohen, M. H., Williams, G., Johnson, J. R., Duan, J. Z., Gobburu, J. V. S., Rahman, A., Benson, K. A., Leighton, J. K., Kim, S. K., Wood, R., et al. (2002) · PubMed · Cited by 462
Siena, S., Sartore-Bianchi, A., Di Nicolantonio, F., Balfour, J., & Bardelli, A. (2009) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp280 · Cited by 429 · cited 1×
“, the use of monoclonal antibodies that target the epidermal growth factor receptor (EGFR) in patients with EGFR-expressing metastatic colon cance”
Should donors be allowed to give broad consent to future biobank research?
Hansson, M. G., Dillner, J., Bartram, C. R., Carlson, J. A., & Helgesson, G. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70618-0 · Cited by 382
Burton, P. R., Hansell, A. L., Fortier, I., Manolio, T. A., Khoury, M. J., Little, J., & Elliott, P. (2009) · International Journal of Epidemiology · doi:10.1093/ije/dyn147 · Cited by 258
Solidarity and equity: new ethical frameworks for genetic databases
Chadwick, R., & Berg, K. (2001) · Nature Reviews Genetics · doi:10.1038/35066094 · Cited by 254
Elger, B. S., & Caplan, A. L. (2006) · EMBO reports · doi:10.1038/sj.embor.7400740 · Cited by 196
Biomarker-Driven Early Clinical Trials in Oncology: A Paradigm Shift in Drug Development
Tan, D. S. W., Thomas, G. V., Garrett, M. D., Banerji, U., de Bono, J. S., Kaye, S. B., & Workman, P. (2009) · The Cancer Journal · doi:10.1097/ppo.0b013e3181bd0445 · Cited by 171
End points in cancer clinical trials and the drug approval process.
Schilsky, R. L. (2002) · PubMed · Cited by 170
A Perspective on Challenges and Issues in Biomarker Development and Drug and Biomarker Codevelopment
Taube, S. E., Clark, G. M., Dancey, J. E., McShane, L. M., Sigman, C. C., & Gutman, S. I. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp334 · Cited by 158
Rules for Research on Human Genetic Variation — Lessons from Iceland
Annas, G. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006153422412 · Cited by 115 · cited 1×
“To what extent can such consent about the unknown future be accurately described as informed consent”
The role of the pathologist in tissue banking: European Consensus Expert Group Report
Bevilacqua, G., Bosman, F. T., Dassesse, T., Höfler, H., Janin, A., Langer, R., Larsimont, D., Morente, M. M., Riegman, P. H. J., Schirmacher, P., et al. (2010) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-010-0887-7 · Cited by 92 · cited 1×
“eu/">BBMRI website; Further information) illustrates moves to coordinate existing biobanking activities across Europ”
Ethical framework for previously collected biobank samples
Helgesson, G., Dillner, J., Carlson, J. A., Bartram, C. R., & HANSSON, M. G. (2007) · Nature Biotechnology · doi:10.1038/nbt0907-973b · Cited by 90 · cited 1×
“To facilitate clear autonomy, transfers of samples and data to third parties must be fully documented for future reference according to standard operating procedure”
International Society for Biological and Environmental Repositories (ISBER) (2005) · Cell Preservation Technology · doi:10.1089/cpt.2005.3.5 · Cited by 90
The consent problem within DNA biobanks
Shickle, D. (2006) · Studies in History and Philosophy of Science Part C Studies in History and Philosophy of Biological and Biomedical Sciences · doi:10.1016/j.shpsc.2006.06.007 · Cited by 87
Biobanks and bioethics: the politics of legitimation
Salter, B., & Jones, M. (2005) · Journal of European Public Policy · doi:10.1080/13501760500160623 · Cited by 86
Assessing the impact of biobanks
Cambon‐Thomsen, A. (2003) · Nature Genetics · doi:10.1038/ng0503-25b · Cited by 85 · cited 1×
“The analysis of subpopulations in these databases has already led to changes in clinical practic”
The Penn Center guide to bioethics
(2009) · Choice Reviews Online · doi:10.5860/choice.47-0909 · Cited by 84
Ownership and Use of Tissue Specimens for Research
Hakimian, R. (2004) · JAMA · doi:10.1001/jama.292.20.2500 · Cited by 78
Informed Consent and Genetic Information
O’Neill, O. (2001) · Studies in History and Philosophy of Science Part C Studies in History and Philosophy of Biological and Biomedical Sciences · doi:10.1016/s1369-8486(01)00026-7 · Cited by 73 · cited 1×
“To what extent can such consent about the unknown future be accurately described as informed consent”
Why have we failed to find the low penetrance genetic constituents of common cancers?
Caporaso, N. E. (2002) · PubMed · Cited by 70
International Society for Biological and Environmental Repositories (ISBER) (2008) · Cell Preservation Technology · doi:10.1089/cpt.2008.9996.bpr · Cited by 36
The Penn Center Guide to Bioethics
Cruz-Oliver, D. M., & Gammack, J. K. (2010) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2009.08.011 · Cited by 34
The Ethical Challenges of Genetic Databases: Safeguarding Altruism and Trust
Campbell, A. V. (2007) · King s Law Journal · doi:10.1080/09615768.2007.11427675 · Cited by 34
An infrastructure for interconnecting research institutions
Buetow, K. H. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.03.011 · Cited by 33 · cited 1×
“gov/">Cancer Bioinformatics Grid website; Further information) is connecting research organizations across the United State”
Genetic research with stored biological materials: ethics and practice.
Wolf, L. E., Bouley, T. A., & McCulloch, C. E. (2010) · PubMed · Cited by 22
Riegman, P. H. J., de Jong, B. W. D., & Llombart‐Bosch, A. (2010) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0062 · Cited by 20
Withdrawing from Participating in a Biobank — A Comparative Study
Gertz, R. (2008) · European Journal of Health Law · doi:10.1163/157180908x338269 · Cited by 13 · cited 1×
“It is clear that continuing public engagement and the feedback of findings is necessary for an acceptable public profile of biobank”
The Role of Neoadjuvant her2-Targeted Therapies in her2-Overexpressing Breast Cancers
Lemieux, J., Clemons, M. J., Provencher, L., Dent, S., Latreille, J., Mackey, J., Pritchard, K. I., Rayson, D., Verma, S., Verma, S., et al. (2009) · Current Oncology · doi:10.3747/co.v16i5.510 · Cited by 12 · cited 1×
“gov/drugdictionary/?CdrID=42265">trastuzumab (Herceptin; Genentech) in ERBB2-positive breast cancer”
Preface: antibody therapies for cancer
Bonavida, B. (2007) · Oncogene · doi:10.1038/sj.onc.1210369 · Cited by 6 · cited 1×
“The need for large integrated biobanks One of the biggest limiting factors to the successful translation of basic scientific cellular and molecular studies into improved patient outcome has been the lack of access to large, appropriate and well-annotated cohorts of human tissu”
Genetic research & human biological samples: some legal and ethical considerations.
Sheikh, A. A. (2004) · PubMed · Cited by 5
On the relation between induced abortion and breast cancer.
BRIND, J. L., & Chinchilli, V. M. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00723-4 · Cited by 5
Big Databases: Outcomes Research Begins To Yield Results
Goozner, M. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq034 · Cited by 1
Cited by
The ethics of big data: current and foreseeable issues in biomedical contexts
Mittelstadt, B. D., & Floridi, L. (2016) · Science and Engineering Ethics · doi:10.1007/s11948-015-9652-2 · Cited by 714
“For instance, providing data subjects with unrestricted access to raw data may be harmful in the sense that it is practically useless or open to misinterpretation without the presence of a trained clinician or analyst to explain its significance (Watson et al. 2010).”
BackgroundCancer biomarker discovery and validation.
Goossens, N., Nakagawa, S., Sun, X., & Hoshida, Y. (2015) · PubMed · doi:10.3978/j.issn.2218-676x.2015.06.04 · Cited by 503
“However, in part due to the complex and heterogeneous nature of cancer, it has become increasingly recognized, that there is a need for larger integrated biobanks (32,33) which require careful development and adherence to published biobanking guidelines (34).”
BackgroundBiobanking: the foundation of personalized medicine
Hewitt, R. E. (2011) · Current Opinion in Oncology · doi:10.1097/cco.0b013e32834161b8 · Cited by 288
Ethics of the health-related internet of things: a narrative review
Mittelstadt, B. (2017) · Ethics and Information Technology · doi:10.1007/s10676-017-9426-4 · Cited by 154
The Ethics of Big Data: Current and Foreseeable Issues in Biomedical Contexts
Mittelstadt, B. D., & Floridi, L. (2016) · Law, Governance and Technology Series · doi:10.1007/978-3-319-33525-4_19 · Cited by 159
Metadata
- Authors
- Watson, R. W. G., Kay, E. W., & Smith, D.
- Affiliations
- University College Dublin (IE)
- Royal College of Surgeons in Ireland (IE)
- Corresponding author
- Watson, R. William G.
- Venue
- Nature Reviews Cancer
- Published
- 2010-08-12
- Volume
- 10
- Issue
- 9
- Pages
- 646-651
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2030361273
- Cited by
- 88
- References
- 32
- Citations by year
- 2026: 2 · 2024: 1 · 2023: 4 · 2022: 5 · 2021: 15 · 2020: 4 · 2019: 3 · 2018: 9 · 2017: 6 · 2016: 6 · 2015: 5 · 2014: 4 · 2013: 4 · 2012: 11
- FWCI
- 1.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- DigitalGeorgetown (Georgetown University Library) (submittedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics in Clinical Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Science, Research, and Medicine
- Health Sciences › Nursing › Issues, ethics and legal aspects › Biomedical Ethics and Regulation
- Keywords
- cancer research, research ethics, public trust, biobank governance, sample diversity, tumor heterogeneity
- MeSH terms
- Animals, Humans, Neoplasms, Guidelines as Topic, Biological Specimen Banks, Bioethical Issues, Ethics, Research
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.